title: Macrophage mannose receptor on lymphatics controls cell trafficking.
abstract: Macrophage mannose receptor (MR) participates in pathogen recognition, clearance of endogenous serum glycoproteins, and antigen presentation. MR is also present on lymphatic vessels, where its function is unknown. Here we show that migration of lymphocytes from the skin into the draining lymph nodes through the afferent lymphatics is reduced in MR-deficient mice, while the structure of lymphatic vasculature remains normal in these animals. Moreover, in a tumor model the primary tumors grow significantly bigger in MR(-/-) mice than in the wild-type (WT) controls, whereas the regional lymph node metastases are markedly smaller. Adhesion of both normal lymphocytes and tumor cells to lymphatic vessels is significantly decreased in MR-deficient mice. The ability of macrophages to present tumor antigens is indistinguishable between the 2 genotypes. Thus, MR on lymphatic endothelial cells is involved in leukocyte trafficking and contributes to the metastatic behavior of cancer cells. Blocking of MR may provide a new approach to controlling inflammation and cancer metastasis by targeting the lymphatic vasculature.
authors.affiliation: MediCity Research Laboratory and Department of Medical Microbiology, Turku University and National Public Health Institute, Turku, Finland.
authors.forename: Fumiko
authors.initials: F
authors.lastname: Marttila-Ichihara
authors.forename: Raisa
authors.initials: R
authors.lastname: Turja
authors.forename: Mari
authors.initials: M
authors.lastname: Miiluniemi
authors.forename: Marika
authors.initials: M
authors.lastname: Karikoski
authors.forename: Mikael
authors.initials: M
authors.lastname: Maksimow
authors.forename: Jussi
authors.initials: J
authors.lastname: Niemelä
authors.forename: Luisa
authors.initials: L
authors.lastname: Martinez-Pomares
authors.forename: Marko
authors.initials: M
authors.lastname: Salmi
authors.forename: Sirpa
authors.initials: S
authors.lastname: Jalkanen
mesh_terms: D000818:Animals; D017951:Antigen Presentation; D000951:Antigens, Neoplasm; D001402:B-Lymphocytes / Q000276:immunology / Q000502:physiology; D002448:Cell Adhesion; D045744:Cell Line, Tumor; D002465:Cell Movement; D003713:Dendritic Cells / Q000276:immunology / Q000473:pathology; D005260:Female; D037181:Lectins, C-Type / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D008207:Lymphatic Metastasis; D008208:Lymphatic System / Q000166:cytology / Q000502:physiology*; D008264:Macrophages / Q000276:immunology / Q000502:physiology*; D008297:Male; D000090323:Mannose Receptor; D037241:Mannose-Binding Lectins / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D008546:Melanoma, Experimental / Q000276:immunology / Q000473:pathology / Q000556:secondary; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D011956:Receptors, Cell Surface / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D013601:T-Lymphocytes / Q000276:immunology / Q000502:physiology
chemical_list: D000951:Antigens, Neoplasm; D037181:Lectins, C-Type; D000090323:Mannose Receptor; D037241:Mannose-Binding Lectins; D011956:Receptors, Cell Surface